Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	31.85	26.29	30.78	109.28	52.25	31.8
Short-Term Investments	95.95	99.72	116.14	46.04	71.02	59.04
Cash & Short-Term Investments	127.79	126	146.91	155.32	123.27	90.83
Cash Growth	-4.76%	-14.23%	-5.41%	26.00%	35.71%	-27.11%
Accounts Receivable	1.61	1.78	1.35	0.9	1.31	1.2
Other Receivables	0.3	-	-	-	-	-
Receivables	1.91	1.78	1.35	0.9	1.31	1.2
Prepaid Expenses	3.08	4.25	2.87	4.45	3.12	1.79
Total Current Assets	132.78	132.03	151.14	160.66	127.7	93.83
Property, Plant & Equipment	4.7	6.09	6.81	8.08	9.33	11.41
Long-Term Investments	2.96	6.28	37.36	35.69	-	-
Other Long-Term Assets	-	-	0.1	0.06	0.04	0.29
Total Assets	140.44	144.4	195.42	204.49	137.08	105.54
Accounts Payable	2.32	3.22	3.52	3.17	2.99	2.4
Accrued Expenses	4.66	7.05	12.51	7.66	6.16	4.95
Current Portion of Leases	0.47	0.43	0.37	0.38	0.39	0.34
Current Unearned Revenue	10.91	11.79	16.46	-	-	-
Other Current Liabilities	0.57	-	-	-	-	0.14
Total Current Liabilities	18.92	22.49	32.86	11.22	9.54	7.83
Long-Term Debt	5.32	6.95	10.37	16.3	19.55	18.99
Long-Term Leases	0.98	1.34	1.82	2.23	2.59	3.02
Long-Term Unearned Revenue	-	-	6	-	-	-
Other Long-Term Liabilities	8.34	7.6	7.53	5.3	3.43	2.95
Total Liabilities	33.55	38.38	58.57	35.05	35.11	32.79
Common Stock	1,408	1,350	1,319	1,287	985.94	898.54
Additional Paid-In Capital	81.43	81.27	72.41	65.49	60.75	55.25
Retained Earnings	-1,334	-1,277	-1,204	-1,134	-1,046	-970.09
Comprehensive Income & Other	-48.09	-48.42	-50.49	-48.34	-48.17	-48.23
Total Common Equity	106.89	106.02	136.85	169.44	-47.44	-64.54
Shareholders' Equity	106.89	106.02	136.85	169.44	101.97	72.74
Total Liabilities & Equity	140.44	144.4	195.42	204.49	137.08	105.54
Total Debt	6.76	8.72	12.55	18.91	22.54	22.35
Net Cash (Debt)	124	123.57	171.72	172.1	100.73	68.48
Net Cash Growth	-7.92%	-28.04%	-0.22%	70.85%	47.09%	-45.04%
Net Cash Per Share	0.69	0.74	1.14	1.62	1.33	1.20
Filing Date Shares Outstanding	189.49	179.49	162.57	148.64	95.58	68.94
Total Common Shares Outstanding	189.44	169.87	157.46	144.99	89.68	64.78
Working Capital	113.85	109.54	118.28	149.44	118.16	86
Book Value Per Share	0.56	0.62	0.87	1.17	-0.53	-1.00
Tangible Book Value	106.89	106.02	136.85	169.44	-47.44	-64.54
Tangible Book Value Per Share	0.56	0.62	0.87	1.17	-0.53	-1.00
Machinery	-	7.98	7.28	6.79	5.99	5.8
Leasehold Improvements	-	8.59	8.59	8.56	8.56	8.52

Source: S&P Capital IQ. Standard template. Financial Sources.